Literature DB >> 28193718

H-Ras Isoform Mediates Protection Against Pressure Overload-Induced Cardiac Dysfunction in Part Through Activation of AKT.

Takahisa Matsuda1, Jae Im Jeong1, Shohei Ikeda1, Takanobu Yamamoto1, Shumin Gao1, Gopal J Babu1, Peiyong Zhai1, Dominic P Del Re2.   

Abstract

BACKGROUND: In general, Ras proteins are thought to promote cardiac hypertrophy, an important risk factor for cardiovascular disease and heart failure. However, the contribution of different Ras isoforms has not been investigated. The objective of this study was to define the role of H- and K-Ras in modulating stress-induced myocardial hypertrophy and failure. METHODS AND
RESULTS: We used H- and K-Ras gene knockout mice and subjected them to pressure overload to induce cardiac hypertrophy and dysfunction. We observed a worsened cardiac phenotype in Hras-/- mice, while outcomes were improved in Kras+/- mice. We also used a neonatal rat cardiomyocyte culture system to elucidate the mechanisms underlying these observations. Our findings demonstrate that H-Ras, but not K-Ras, promotes cardiomyocyte hypertrophy both in vivo and in vitro. This response was mediated in part through the phosphoinositide 3-kinase-AKT signaling pathway. Adeno-associated virus-mediated increase in AKT activation improved the cardiac function in pressure overloaded Hras null hearts in vivo. These findings further support engagement of the phosphoinositide 3-kinase-AKT signaling axis by H-Ras.
CONCLUSIONS: Taken together, these findings indicate that H- and K-Ras have divergent effects on cardiac hypertrophy and heart failure in response to pressure overload stress.
© 2017 American Heart Association, Inc.

Entities:  

Keywords:  Ras proteins; cardiomyocytes; heart failure; hypertension; hypertrophy

Mesh:

Substances:

Year:  2017        PMID: 28193718      PMCID: PMC5325037          DOI: 10.1161/CIRCHEARTFAILURE.116.003658

Source DB:  PubMed          Journal:  Circ Heart Fail        ISSN: 1941-3289            Impact factor:   8.790


  50 in total

1.  Phospholipase C(epsilon): a novel Ras effector.

Authors:  G G Kelley; S E Reks; J M Ondrako; A V Smrcka
Journal:  EMBO J       Date:  2001-02-15       Impact factor: 11.598

2.  Tiam1 mediates Ras activation of Rac by a PI(3)K-independent mechanism.

Authors:  John M Lambert; Que T Lambert; Gary W Reuther; Angeliki Malliri; David P Siderovski; John Sondek; John G Collard; Channing J Der
Journal:  Nat Cell Biol       Date:  2002-08       Impact factor: 28.824

3.  The Catalogue of Somatic Mutations in Cancer (COSMIC).

Authors:  S A Forbes; G Bhamra; S Bamford; E Dawson; C Kok; J Clements; A Menzies; J W Teague; P A Futreal; M R Stratton
Journal:  Curr Protoc Hum Genet       Date:  2008-04

4.  Adenoviral gene transfer of Akt enhances myocardial contractility and intracellular calcium handling.

Authors:  A Cittadini; M G Monti; G Iaccarino; F Di Rella; P N Tsichlis; A Di Gianni; H Strömer; D Sorriento; C Peschle; B Trimarco; L Saccà; G Condorelli
Journal:  Gene Ther       Date:  2006-01       Impact factor: 5.250

5.  Identification of the guanine nucleotide dissociation stimulator for Ral as a putative effector molecule of R-ras, H-ras, K-ras, and Rap.

Authors:  M Spaargaren; J R Bischoff
Journal:  Proc Natl Acad Sci U S A       Date:  1994-12-20       Impact factor: 11.205

6.  Mechanism of enhanced cardiac function in mice with hypertrophy induced by overexpressed Akt.

Authors:  Young-Kwon Kim; Song-Jung Kim; Atsuko Yatani; Yanhong Huang; Germana Castelli; Dorothy E Vatner; Jing Liu; Qizhi Zhang; Gissela Diaz; Renata Zieba; Jill Thaisz; Alessandra Drusco; Carlo Croce; Junichi Sadoshima; Gianluigi Condorelli; Stephen F Vatner
Journal:  J Biol Chem       Date:  2003-09-16       Impact factor: 5.157

7.  Ventricular expression of a MLC-2v-ras fusion gene induces cardiac hypertrophy and selective diastolic dysfunction in transgenic mice.

Authors:  J J Hunter; N Tanaka; H A Rockman; J Ross; K R Chien
Journal:  J Biol Chem       Date:  1995-09-29       Impact factor: 5.157

8.  Direct interaction of Ras and the amino-terminal region of Raf-1 in vitro.

Authors:  P H Warne; P R Viciana; J Downward
Journal:  Nature       Date:  1993-07-22       Impact factor: 49.962

9.  Genetic inhibition of cardiac ERK1/2 promotes stress-induced apoptosis and heart failure but has no effect on hypertrophy in vivo.

Authors:  Nicole H Purcell; Benjamin J Wilkins; Allen York; Marc K Saba-El-Leil; Sylvain Meloche; Jeffrey Robbins; Jeffery D Molkentin
Journal:  Proc Natl Acad Sci U S A       Date:  2007-08-20       Impact factor: 11.205

10.  Germline KRAS mutations cause Noonan syndrome.

Authors:  Suzanne Schubbert; Martin Zenker; Sara L Rowe; Silke Böll; Cornelia Klein; Gideon Bollag; Ineke van der Burgt; Luciana Musante; Vera Kalscheuer; Lars-Erik Wehner; Hoa Nguyen; Brian West; Kam Y J Zhang; Erik Sistermans; Anita Rauch; Charlotte M Niemeyer; Kevin Shannon; Christian P Kratz
Journal:  Nat Genet       Date:  2006-02-12       Impact factor: 38.330

View more
  4 in total

1.  The tumor suppressor RASSF1A modulates inflammation and injury in the reperfused murine myocardium.

Authors:  Jamie Francisco; Jaemin Byun; Yu Zhang; Olivia Berman Kalloo; Wataru Mizushima; Shinichi Oka; Peiyong Zhai; Junichi Sadoshima; Dominic P Del Re
Journal:  J Biol Chem       Date:  2019-07-16       Impact factor: 5.157

2.  AAV-mediated YAP expression in cardiac fibroblasts promotes inflammation and increases fibrosis.

Authors:  Jamie Francisco; Yu Zhang; Yasuki Nakada; Jae Im Jeong; Chun-Yang Huang; Andreas Ivessa; Shinichi Oka; Gopal J Babu; Dominic P Del Re
Journal:  Sci Rep       Date:  2021-05-18       Impact factor: 4.379

3.  Rap1GAP Mediates Angiotensin II-Induced Cardiomyocyte Hypertrophy by Inhibiting Autophagy and Increasing Oxidative Stress.

Authors:  Yan Gao; Di Zhao; Wen-Zhi Xie; Tingting Meng; Chunxiao Xu; Yutong Liu; Pengfei Zhang; Xiuping Bi; Zhuo Zhao
Journal:  Oxid Med Cell Longev       Date:  2021-04-15       Impact factor: 6.543

Review 4.  Molecules linked to Ras signaling as therapeutic targets in cardiac pathologies.

Authors:  Manuel Ramos-Kuri; Sri Harika Meka; Fabio Salamanca-Buentello; Roger J Hajjar; Larissa Lipskaia; Elie R Chemaly
Journal:  Biol Res       Date:  2021-08-03       Impact factor: 5.612

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.